Founded Date:
1992-02-11
Technology:
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Funding Status:
IPO
Total Funding:
407231243.0
Employee Number:
101-250
Headquarters:
New York, New York, United States
Last Funding Date:
2017-09-05
Investors Number:
1.0
Last Funding Type:
Post-IPO Debt
Estimated Revenue:
$10M to $50M
Industry:
Early Drug Development